Breaks Categories: News

ThursdayJan 27, 2022 10:31 am

CannabisNewsBreaks – RYAH Group Inc. (CSE: RYAH) Announces MOU with Bazelet Pharma Ltd., Closing of Initial Tranche of Private Placement

RYAH Group (CSE: RYAH) today announced its entry into a memorandum of understanding (“MOU”) with Bazelet Pharma Ltd. and affiliates (together, “Bazelet”), the largest medical cannabis processing company in Israel, serving thousands of patients. According to the update, the collaboration is aimed at servicing Bazelet's patients using RYAH Smart Inhalers and data analytics, once certified as a medical device in Israel, with the goal of providing safe and accurate patient inhalation therapies in plant medicine. “Bazelet brings extraordinary depth and expertise within a well-established and fast-growing medical cannabis market. We're excited to be collaborating with Bazelet in bringing our smart…

Continue Reading

MondayJan 24, 2022 1:56 pm

CannabisNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Appoints Renowned Genetics, Cultivation Expert as Advisor

Flora Growth’s (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, has named Derek Pedro, an industry-leading cannabis genetics and cultivation expert, as an advisor. Pedro is recognized as a pioneer in the cannabis industry and has consulted on cannabis genetic and cultivation projects around the world, including Canada, the United States, Latin America, Europe and China. In his role at FLGC, he will focus on developing the company’s current register of high-THC and high-CBD strains. The company hopes to offer cannabis flower offerings that are uniquely Colombian to both domestic and international markets. Flora…

Continue Reading

WednesdayJan 19, 2022 12:12 pm

CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Expands Rare Cannabinoid Product Portfolio to Launch CBT

InMed Pharmaceuticals (NASDAQ: INM), a leader in the research, development, manufacturing and commercialization of rare cannabinoids, today announced that it has launched B2B sales of the rare cannabinoid cannabicitran (“CBT”) into the health and wellness sector. According to the update, CBT is the first of several new product launches the company has planned for the first half of 2022. “We are delivering on our objective to launch additional rare cannabinoids in early 2022 in response to inbound demand. By midyear, we expect to have at least four rare cannabinoids available for the health and wellness markets, positioning us as a…

Continue Reading

TuesdayJan 18, 2022 4:11 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Provides Comments Regarding Study Examining Cannabinoids and SARS-CoV-2

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug-delivery platforms, has commented on a recent study that indicated that cannabinoids have the potential to prevent as well as treat infection by SARS-CoV-2. The comments came from lead research scientist Dr. Richard van Breeman, who granted an interview with vice.com discussing the independent study. In his comments, Breemen observed that smoking or vaping of cannabis was likely not effective, but oral delivery was, causing Breeman to recommend oral administration of cannabis compounds. Lexaria is keenly interested in the study because the company is actively engaged in research with its exclusive DehydraTECH(TM)-powered cannabinoid formulations,…

Continue Reading

TuesdayJan 18, 2022 12:00 pm

CannabisNewsBreaks – Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) to Centralize Distribution for ‘House of Premium Brands’ in Michigan

Red White & Bloom Brands (CSE: RWB) (OTCQX: RWBYF) is a multistate cannabis operator and house of premium brands. The company, via its RWB Michigan LLC wholly owned subsidiary, has closed on a lease assignment for a 15,000-square-foot manufacturing/processing and distribution facility in Warren, Michigan, and has been issued both medical and adult use (aka “recreational”) licenses. “This Warren facility allows us to centralize distribution for our ‘house of premium brands’ in Michigan and finally report all of our Platinum Vape(TM) wholesale sales on a much less confusing and straightforward basis,” said RWB CEO and Chairman Brad Rogers. “We will…

Continue Reading

TuesdayJan 11, 2022 11:44 am

CannabisNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Announces Completion of First Cannabis Extraction Through New Facility

Flora Growth’s (NASDAQ: FLGC) wholly owned subsidiary, Cosechemos, has produced the first batch of crude oil through its newly constructed extraction facility. FLGC, a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, made the announcement, adding that the 10,500-square-foot plant, which has an annual capacity to produce 15,000 L of distillate, is also taking steps to become EU-GMP certified. Full certification will allow the company to export medical-grade cannabis derivatives to international markets. The plant is Flora Growth’s primary processing location and facilitates the drying and processing of the company’s all-outdoor cultivated flower into finished, packaged dry…

Continue Reading

ThursdayJan 06, 2022 11:14 am

CannabisNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Announces Strategic Advisory Board Appointment

Flora (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, today announced the appointment of accomplished business leader and cannabis industry expert Tim Leslie as the chairman of its newly formed advisory board. Establishment of the advisory board comes as Flora continues to develop its corporate structure to include a robust roster of human capital. Leslie’s appointment aligns with the company’s goal of working with the industry’s best leaders to provide strategic counsel on matters that will fuel its growth. “We are pleased and honored to have Tim join us as the first chairman of…

Continue Reading

ThursdayDec 30, 2021 10:37 am

CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) to Present at Tribe Public’s Webinar Event

InMed Pharmaceuticals (NASDAQ: INM), a leader in the development, manufacturing and commercialization of rare cannabinoids, today announced that its CEO Eric A. Adams, SVP and General Manager of BayMedica, Shane Johnson, and VP of Commercial Operations Chris Meiering will present at Tribe Public’s upcoming webinar presentation and Q&A event. The event, titled “Addressing the Increasing Demand for Rare Cannabinoids,” is slated to begin at 8 a.m. Pacific/11.a.m. Eastern on Jan. 6, 2022. Interested parties should visit https://cnw.fm/rKO43 to register to join the complimentary, ZOOM webinar-based event. Once registered, participants may begin forwarding their questions for InMed and BayMedica’s management to…

Continue Reading

WednesdayDec 29, 2021 1:05 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Approval from Independent Review Board for DehydraTECH-CBD Human Clinical Study

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug-delivery platforms, has received Independent Review Board ("IRB") approval for its planned DehydraTECH-CBD human hypertension study HYPER-H21-4; the approval was received earlier than anticipated. The study is designed to "de-risk" outcomes prior to the company’s planned entry into regulatory pathways for the use of DehydraTECH-CBD to treat hypertension and perhaps other forms of cardiovascular disease. The six-week study, which is entirely funded through the existing cash resources, is planned to include 60 volunteers, aged 45 to 70, using three 150 mg doses of DehydraTECH-CBD daily for the duration of the study. Dosing…

Continue Reading

WednesdayDec 22, 2021 11:46 am

CannabisNewsBreaks – Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Partners with Avicanna to Launch New Derma-Cosmetic Brand

Red White & Bloom (CSE: RWB) (OTCQX: RWBYF), a multistate cannabis operator and house of premium brands, is working with Avicanna Inc. (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) to unveil a new THC-free, CBD derma-cosmetic brand. The first known CBD skincare line to be clinically tested and commercialized across four international markets, Pura H&W will include seven SKUs of proprietary products. The products are formulated using a combination of purified CBD and other synergistic botanical ingredients designed to naturally regulate and nourish the skin. The Pura H&W product line was developed by Avicanna and specific products have undergone clinical trials.…

Continue Reading